Medibank Private 관리

관리 기준 확인 4/4

Medibank Private CEO는 David Koczkar, May2021 에 임명되었습니다 의 임기는 3.5 년입니다. 총 연간 보상은 A$ 80.11K, 34.8% 로 구성됩니다. 34.8% 급여 및 65.2% 보너스(회사 주식 및 옵션 포함). 는 € 4.35M 가치에 해당하는 회사 주식의 0.068% 직접 소유합니다. 4.35M. 경영진과 이사회의 평균 재임 기간은 각각 3.5 년과 3.5 년입니다.

주요 정보

David Koczkar

최고 경영자

AU$80.1k

총 보상

CEO 급여 비율	34.8%
CEO 임기	3.5yrs
CEO 소유권	0.07%
경영진 평균 재임 기간	3.5yrs
이사회 평균 재임 기간	3.5yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

David Koczkar 의 보수는 Medibank Private 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Jun 30 2024	AU$80k	AU$28k	AU$4m
Mar 31 2024	n/a	n/a	AU$89m
Dec 31 2023	n/a	n/a	AU$685m
Sep 30 2023	n/a	n/a	AU$598m
Jun 30 2023	AU$3m	AU$2m	AU$0
Mar 31 2023	n/a	n/a	AU$171m
Dec 31 2022	n/a	n/a	AU$343m
Sep 30 2022	n/a	n/a	AU$368m
Jun 30 2022	AU$4m	AU$2m	AU$394m
Mar 31 2022	n/a	n/a	AU$414m
Dec 31 2021	n/a	n/a	AU$435m
Sep 30 2021	n/a	n/a	AU$438m
Jun 30 2021	AU$2m	AU$1m	AU$441m
Mar 31 2021	n/a	n/a	AU$402m
Dec 31 2020	n/a	n/a	AU$363m
Sep 30 2020	n/a	n/a	AU$340m
Jun 30 2020	AU$1m	AU$919k	AU$316m
Mar 31 2020	n/a	n/a	AU$368m
Dec 31 2019	n/a	n/a	AU$420m
Sep 30 2019	n/a	n/a	AU$429m
Jun 30 2019	AU$2m	AU$866k	AU$438m
Dec 31 2018	n/a	n/a	AU$375m
Sep 30 2018	n/a	n/a	AU$400m
Jun 30 2018	AU$2m	AU$802k	AU$424m

보상 대 시장: David 의 총 보상 ($USD 52.06K ) German 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 3.59M ).

보상과 수익: David 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

David Koczkar (51 yo)

3.5yrs

테뉴어

AU$80,106

보상

Mr. David Koczkar, BCom, PG Dip Finance, MAICD, serves as Managing Director, Director and Chief Executive Officer at Medibank Private Limited since May 17, 2021 and served as Group Executive and Chief Cust...

리더십 팀

이름	위치	테뉴어	보상	소유권
David Koczkar	CEO, MD & Director	3.5yrs	AU$80.11k	0.068% € 4.4m
Mark Rogers	Group Lead - Chief Financial Officer & Group Strategy	7.8yrs	AU$39.24k	0.029% € 1.9m
Andrew Wilson	Group Chief Medical Officer	14.3yrs	AU$25.02k	0% € 0
Milosh Milisavljevic	Group Lead - Chief Customer Officer	3.4yrs	AU$34.73k	0.0057% € 359.9k
Robert Read	Group Lead – Amplar Health	less than a year	AU$19.03k	데이터 없음
Felicia Trewin	Group Lead – Data & Technology	less than a year	데이터 없음	데이터 없음
Colette Campbell	Senior Executive of Investor Relations	no data	데이터 없음	데이터 없음
Mei Ramsay	Group Lead – Trust	10.1yrs	AU$1.03m	데이터 없음
Tom Exton	Group Lead - Chief Risk & Compliance Officer	less than a year	데이터 없음	데이터 없음
Emily Ritchie	Senior Executive of External Affairs	no data	데이터 없음	데이터 없음
Kylie Bishop	Group Lead – People	11.3yrs	AU$1.10m	데이터 없음
Meaghan Telford	Group Lead of Policy	no data	데이터 없음	데이터 없음

3.5yrs

평균 재임 기간

경험이 풍부한 관리: MPV 의 관리팀은 경험 ( 3.5 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
David Koczkar	CEO, MD & Director	3.5yrs	AU$80.11k	0.068% € 4.4m
Linda Nicholls	Independent Non-Executive Director	10.7yrs	AU$4.23k	0.0018% € 116.4k
Kathryn Fagg	Independent Non-Executive Director	2.7yrs	AU$3.80k	0.0024% € 151.3k
Michael Wilkins	Independent Non-Executive Chairman	7.5yrs	AU$8.33k	0.0073% € 461.7k
Peter Everingham	Independent Non-Executive Director	2.7yrs	AU$3.89k	0.0014% € 92.2k
Tracey Batten	Independent Non-Executive Director	7.3yrs	AU$4.22k	0.0018% € 115.7k
David Fagan	Independent Non-Executive Director	10.7yrs	AU$4.23k	0.0017% € 108.7k
Gerard Dalbosco	Independent Non-Executive Director	3.5yrs	AU$4.23k	0.0026% € 167.9k
Jay Weatherill	Independent Non-Executive Director	less than a year	AU$1.10k	0.00061% € 38.8k

3.5yrs

평균 재임 기간

61yo

평균 연령

경험이 풍부한 이사회: MPV 의 이사회는 경험(평균 재직 기간 3.5 년)으로 간주됩니다.

Medibank Private 관리

관리 기준 확인 4/4

주요 정보

최근 관리 업데이트

Medibank Private Limited, Annual General Meeting, Nov 13, 2024

High number of new directors

Medibank Private Limited Announces Changes to Executive Leadership Team

Anna Bligh to Retire as Non-Executive Director of Medibank Private Limited At the Conclusion its Annual General Meeting on 22 November 2023

Medibank Private Limited Announces Executive Changes, Effective 31 July 2023

Independent Non-Executive Director recently bought €102k worth of stock

Recent updates

Medibank Private Limited, Annual General Meeting, Nov 13, 2024

Final dividend of AU$0.094 announced

Medibank Private Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on September 26, 2024

Full year 2024 earnings released: EPS: AU$0.18 (vs AU$0.19 in FY 2023)

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 18%

Now 35% undervalued after recent price drop

High number of new directors

First half dividend of AU$0.072 announced

First half 2024 earnings released: EPS: AU$0.13 (vs AU$0.061 in 1H 2023)

Medibank Private Limited to Report First Half, 2024 Results on Feb 22, 2024

Medibank Private Limited Announces Changes to Executive Leadership Team

Anna Bligh to Retire as Non-Executive Director of Medibank Private Limited At the Conclusion its Annual General Meeting on 22 November 2023

Upcoming dividend of AU$0.083 per share at 4.1% yield

Medibank Private Limited Fully Franked Final Ordinary Dividend for the Six Months Ended 30 June 2023, Payable on 5 October 2023

Full year 2023 earnings released: EPS: AU$0.19 (vs AU$0.14 in FY 2022)

Medibank Private Limited Announces Executive Changes, Effective 31 July 2023

Now 20% undervalued after recent price drop

Medibank Private Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

First half 2023 earnings released: EPS: AU$0.085 (vs AU$0.08 in 1H 2022)

Now 20% undervalued

Medibank Announces Class Action Filed in the Federal Court of Australia

Medibank Private Limited to Report First Half, 2023 Results on Feb 23, 2023

Investor sentiment deteriorated over the past week

Upcoming dividend of AU$0.073 per share

Full year 2022 earnings released: EPS: AU$0.14 (vs AU$0.16 in FY 2021)

Medibank Private Limited Announces Distribution for the Six Months Ended June 30, 2022, Payable on September 29, 2022

Healius Reportedly Launches Day Surgery Sale Process

Medibank Private Limited to Report Fiscal Year 2022 Results on Aug 18, 2022

Independent Non-Executive Director recently bought €102k worth of stock

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Medibank Private Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended December 31, 2021, Payable on March 24, 2022

Medibank Private Limited Appoints Kathryn Fagg Ao and Peter Everingham as Non-Executive Directors Effective 31 March 2022

Upcoming dividend of AU$0.069 per share

Full year 2021 earnings released: EPS AU$0.16 (vs AU$0.12 in FY 2020)

Medibank Private Limited Provides Earnings Guidance for 2022

CEO & Director Craig Drummond has left the company

Revenue misses expectations

First half 2021 earnings released: EPS AU$0.082 (vs AU$0.065 in 1H 2020)

Craig Drummond to Retire as Chief Executive Officer of Medibank Private Limited on 30 June 2021

Medibank Private Limited (ASX:MPL) entered into share purchase agreement to acquire 49%stake in Myhealth Medical Holdings Pty Ltd from Crescent Capital Partners Management Pty Ltd and others for AUD 63 million.

New 90-day high: €1.88

Medibank Private Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: €1.85

New 90-day high: €1.72

Independent Non-Executive Director recently bought €70k worth of stock

New 90-day low - €1.65

Full year earnings released - EPS €0.11

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

이사회 구성원

평균 재임 기간

평균 연령